Daniel J. Roberts

FDA investigator

Appears on 14 documents from 2011 to 2017, mostly at sites in India. Most often cites production record review (21 CFR 211.192).

14
Documents on file
5.9
Observations per 483
2011
First seen
2017
Most recent

What they cite most

From 80 observations

Activity by year

2011: 2, 2013: 1, 2014: 1, 2015: 3, 2016: 4, 2017: 3

Where

India 8 · California 5 · Canada 1

Is Daniel J. Roberts coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

14 documents, newest first
FirmOpen
483 Intas Pharmaceuticals LimitedMay 10, 2017 · Ahmedabad, India
483 Sun Pharmaceuticals Industries Ltd.Apr 13, 2017 · Dadra, India
483 Mylan Laboratories LimitedFeb 1, 2017 · Bollaram, Jinnaram Mandal, Medak District, India
483 Sun Pharmaceuticals Industries, IncNov 16, 2016 · S.A.S. Nagar, Mohali, India
483 Form 483 · FEI 3004058356Aug 19, 2016 · Pune, India
483 Sun Pharmaceuticals Industries, Inc. SEZ Unit-l, Plot A-41, Industrial Area, Phase VIII-AJul 16, 2016 · S.A.S, India
483 Amoli Organics Pvt. LimitedFeb 12, 2016 · Vapi, India

About this profile

What does Daniel J. Roberts inspect?

Daniel J. Roberts appears on 14 documents on file covering 12 sites, mostly in India.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.194 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Daniel J. Roberts is dated May 10, 2017.

FDA Investigator Daniel J. Roberts: 483s & Inspections · FDA Intel